BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2026 6:38:35 AM | Browse: 5 | Download: 1
 |
Received |
|
2026-02-24 05:46 |
|
Peer-Review Started |
|
2026-02-24 05:48 |
|
First Decision by Editorial Office Director |
|
2026-03-27 12:54 |
|
Return for Revision |
|
2026-03-27 12:54 |
|
Revised |
|
2026-04-04 14:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-05-12 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-12 08:30 |
|
Articles in Press |
|
2026-05-12 08:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-09 09:40 |
|
Publish the Manuscript Online |
|
2026-08-25 06:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Autoantibody profiling in gastric cancer immunotherapy - dynamic monitoring, toxicity-benefit trade-off, and immune endotypes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Wan-Ting Huang, Bin-Bin Zhang and Jia-Nan Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Funds of China |
No. 82204827 |
|
| Corresponding Author |
Jia-Nan Zhao, Academic Fellow, Department of Cardiovascular Sciences, Temple University, North Carlisle Street, 3440 Carlisle st, Philadelphia, PA 19140, United States. tuv36393@temple.edu |
| Key Words |
Gastric cancer; Antinuclear antibody; Extractable nuclear antigen; Immunotherapy; Immune endotype |
| Core Tip |
Baseline antinuclear antibody/extractable nuclear antigen status may serve as a potential predictor of immunotherapy outcomes in gastric cancer. However, static indicators fail to capture dynamic autoantibody changes or the underlying differences in immune endotypes. We propose to build a composite host-tumor model that integrates longitudinal antibody profiles, detailed staining patterns, and safety data, and apply calibration curves and decision curve analysis to evaluate its net clinical benefit, thereby promoting the establishment of more refined risk stratification strategies and facilitating the practice of personalized immuno-oncology. |
| Publish Date |
2026-08-25 06:38 |
| Citation |
Huang WT, Zhang BB, Zhao JN. Letter to the Editor: Autoantibody profiling in gastric cancer immunotherapy - dynamic monitoring, toxicity-benefit trade-off, and immune endotypes. World J Gastroenterol 2026; 32(36): 120350
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i36/120350.htm |
| DOI |
https://doi.org/10.3748/wjg.120350 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
